argenx SE reported 6.1B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
AstraZeneca USD 44.72B 3.68B Jun/2025
Galapagos EUR 2.64B 104.07M Jun/2025
Genmab DKK 5.3B 6M Jun/2025
GlaxoSmithKline GBP 14.35B 197M Jun/2025
GRIFOLS EUR 7.6B 1.96B Jun/2025
Hikma Pharmaceutical USD 2.32B 35M Dec/2024
Qiagen NV USD 3.51B 97.61M Jun/2025
UCB EUR 10.03B 1.08B Dec/2024